Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells

Endocrine-Related Cancer

Volumn 16, Issue 3, 2009, Pages 809-817

  Hyder, Salman M ^a,b   Liang, Yayun ^a   Wu, Jianbo ^a   Welbern, Vanessa ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; GESTAGEN; MESSENGER RNA; NORETHISTERONE; NORGESTREL; PROGESTERONE RECEPTOR; PUROMYCIN; THROMBOSPONDIN 1; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; IN VIVO STUDY; MICROENVIRONMENT; NORTHERN BLOTTING; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA TRANSCRIPTION; TUMOR VASCULARIZATION;

ANIMALS; BIOLOGICAL PRODUCTS; BREAST NEOPLASMS; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY; PROGESTERONE CONGENERS; PROGESTINS; PROMOTER REGIONS, GENETIC; THROMBOSPONDIN 1; TUMOR CELLS, CULTURED;

EID: 72749118508     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0311     Document Type: Article

References (41)

1. Bagavandoss P & Wilks JW 1990 Specific inhibition of endothelial cell proliferation by thrombospondin. Biochemical and Biophysical Research Communications 170 867-872. (Pubitemid 20249499)
2. Bergers G & Benjamin LE 2003 Tumorigenesis and the angiogenic switch. Nature Reviews. Cancer 3 401-410.
3. Byrne GJ, Hayden KE, McDowell G, Lang H, Kirwan CC, Tetlow L, Kumar S & Bundred NJ 2007 Angiogenic characteristics of circulating and tumoural thrombospondin- 1 in breast cancer. International Journal of Oncology 31 1127-1132.
4. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG & Thomson CA 2003 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. Journal of the American Medical Association 289 3243-3253. (Pubitemid 37430077)
5. DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM & Polverini PJ 1996 Thrombospondin-1 synthesis and function in wound repair. American Journal of Pathology 148 1851-1860.
6. Folkman J 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1 27-31.
7. Fontana A, Filleur S, Guglielmi J, Frappart L, Bruno-Bossio G, Boissier S, Cabon F & Clezardin P 2005 Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo. International Journal of Cancer 116 686-691. (Pubitemid 41099699)
8. Giangrande PH, Kimbrel EA, Edwards DP & McDonnell DP 2000 The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Molecular and Cellular Biology 20 3102-3115.
9. Good DJ, Polverini PJ, Rastinejad F, Le-Beau MM, Lemons RS, Frazier WA & Bouck N 1990 A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. PNAS 87 6624-6628. (Pubitemid 20351533)
10. Hyder SM, Stancel GM, Chiappetta C, Murthy L, Boettger- Tong HL & Makela S 1996 Uterine expression of vascular endothelial growth factor is increased by estradiol as well as tamoxifen. Cancer Research 56 3954-3960. (Pubitemid 26284744)
11. Hyder SM, Chiappetta C, Murthy L & Stancel GM 1997 Selective inhibition of estrogen regulated genes in vivo by pure antiestrogen ICI 182,780. Cancer Research 57 2547-2549. (Pubitemid 27283753)
12. Hyder SM, Murthy L & Stancel GM 1998 Progestin regulation of vascular endothelial growth factor in human breast cancer. Cancer Research 58 392-395. (Pubitemid 28087395)
13. Hyder SM, Chiappetta C & Stancel GM 2001 Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. International Journal of Cancer 92 469-473. (Pubitemid 32319417)
14. Hyder SM, Liang Y & Wu J 2009 Estrogen regulation of thrombospondin-1 in breast cancer cells. International Journal of Cancer [in press].
15. Incardona F, Lewalle JM, Morandi V, Lambert S, Legrand Y, Foidart JM & Legrand C 1995 Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells. Cancer Research 55 166-173.
16. Iruela-Arispe ML, Porter P, Bornstein P & Sage EH 1996 Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. Journal of Clinical Investigation 97 403-412. (Pubitemid 26039404)
17. Kodama J, Hashimoto I, Seki N, Hongo A, Yoshinouchi M, Okuda H & Kudo T 2001 Thrombospondin-1 and -2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis. Clinical Cancer Research 7 2826-2831. (Pubitemid 32911392)
18. Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Cushing-Haugen KL & Daling JR 2003 Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. Journal of the American Medical Association 289 3254-3263.
19. Liang Y, Brekken RA & Hyder SM 2006 VEGF induces proliferation of breast cancer cells and counteracts the anti-proliferative activity of anti-hormones. Endocrine Related Cancer 13 905-919. (Pubitemid 44763266)
20. Liang Y, Besch-Williford C, Brekken RA & Hyder SM 2007 Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating anti-tumor therapeutics. Cancer Research 67 9929-9936. (Pubitemid 47621242)
21. Manni A, Badger B, Wright C, Ahmed SR & Demers LM 1987 Effects of progestins on growth of experimental breast cancer in culture: interaction with estradiol and prolactin and involvement of the polyamine pathway. Cancer Research 47 3066-3071. (Pubitemid 17082625)
22. Mirkin S & Archer DF 2004 Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone, and 17β-estradiol on thrombospondin-1 mRNA in Ishikawa cells. Fertility and Sterility 82 220-222. (Pubitemid 38968804)
23. Patel MK, Lymn JS, Clunn GF & Hughes AD 1997 TSP-1 is a powerful mitogen and chemo-attractant for human vascular smooth cells. Arteriosclerosis, Thrombosis, and Vascular Biology 17 2107-2114. (Pubitemid 28057115)
24. Pazouki S, Pendleton N, Heerkens E, Smither RL, Moore JV & Schor AM 1996 Biphasic effect of thrombospondin-1 (TSP-1) in the regulation of angiogenesis in human breast carcinoma. Biochemical Society Transactions 24 368S.
25. Poon RT, Chung KK, Cheung ST, Lau CP, Tong SW, Leung KL, Yu WC, Tuszynski GP & Fan ST 2004 Clinical significance of TSP-1 expression in hepatocellular carcinoma. Clinical Cancer Research 10 4150-4157. (Pubitemid 38812495)
26. Pratt DA, Miller WR & Dawes J 1989 Thrombospondin in malignant and non-malignant breast tissue. European Journal of Cancer & Clinical Oncology 25 343-350. (Pubitemid 19054839)
27. Qian X, Wang TN, Rothman VL, Nicosia RF & Tuszynski GP 1997 Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Experimental Cell Research 235 403-412. (Pubitemid 27398399)
28. Ross RK, Paganini-Hill A, Wan PC & Pike MC 2000 Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Journal of the National Cancer Institute 92 328-332. (Pubitemid 30117736)
29. Sargiannidou I, Zhou J & Tuszynski GP 2001 The role of thrombospondin-1 in tumor progression. Experimental Biology and Medicine 226 726-733.
30. Sengupta K, Banerjee S, Saxena NK & Banerjee SK 2004 Thombospondin-1 disrupts estrogen-induced endothelial cell proliferation and migration and its expression is suppressed by estradiol. Molecular Cancer Research 2 150-158. (Pubitemid 39030305)
31. Sid B, Sartelet H, Bellon G, El Btaouri H, Rath G, Delorme N, Haye B & Martiny L 2004 TSP-1: a multifunctional protein implicated in the regulation of tumor growth. Critical Reviews in Oncology/Hematology 49 245-258. (Pubitemid 38251356)
32. Straume O & Akslen LA 2001 Expression of vascular endothelial growth factor, its receptors (Flt-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. American Journal of Pathology 159 223-235. (Pubitemid 33704207)
33. Sutherland RL, Prall OW, Watts CK & Musgrove EA 1998 Estrogen and progestin regulation of cell cycle progression. Journal of Mammary Gland Biology and Neoplasia 3 63-72. (Pubitemid 128513220)
34. Tobita K, Kijima H, Dowaki S, Oida Y, Kashiwagi H, Ishii M, Sugio Y, Sekka T, Ohtani Y, Tanaka M et al. 2002 Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma. International Journal of Oncology 21 1189-1195.
35. Tonini T, Rossi F & Claudio PP 2003 Molecular basis of angiogenesis and cancer. Oncogene 22 6549-6566.
36. Uray IP, Liang Y & Hyder SM 2004 Estradiol down-regulates CD36 expression in human breast cancer cells. Cancer Letters 20 101-107. (Pubitemid 38429892)
37. Wakiyama T, Shinohara T, Shirakusa T, John AS & Tuszynski G 2001 The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine- cysteine- glycine (CSVTCG) TSP receptor, and matrix metalloproteinase- 9 (MMP-9) in colorectal cancer. Histology and Histopathology 16 345-351. (Pubitemid 32297631)
38. Wang TN, Qian XH, Granick MS, Solomon MP, Rothman VL, Berger DH & Tuszynski GP 1996a Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor. Surgery 120 449-454. (Pubitemid 26287838)
39. Wang TN, Qian XH, Granick MS, Solomon MP, Rothman VL, Berger DH & Tuszynski GP 1996b Thrombospondin- 1 promotes invasive properties of human breast cancer cells. Journal of Surgical Research 63 39-43. (Pubitemid 26197174)
40. Wang-Rodriguez J, Urquidi V, Rivard A & Goodison S 2003 Elevated osteopontin and thrombospondin expression identifies malignant breast carcinoma but is not indicative of metastatic status. Breast Cancer Research 5 R136-R143.
41. Yee KO, Connolly CM, Duquette M, Kazerounian S, Washington R & Lawler J 2009 The effect of thrombospondin-1 on breast cancer metastasis. Breast Cancer Research and Treatment 114 85-96.